SPIA
CBAY

Steward Partners Investment Advisory’s Cymabay Therapeutics CBAY Stock Holding History

Steward Partners Investment Advisory’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,600
Closed -$416K – 3701
2023
Q4 		$416K Buy
17,600
+2,250
+15% +$40.1K 0.01% 1077
2023
Q3 		$229K Buy
+15,350
New +$204K ﹤0.01% 1222
2023
Q2 		– Sell
-500
Closed -$4.36K – 3402
2023
Q1 		$4.36K Hold
500
– – ﹤0.01% 2819
2022
Q4 		$3.13K Hold
500
– – ﹤0.01% 2916
2022
Q3 		$2K Hold
500
– – ﹤0.01% 3081
2022
Q2 		$1K Hold
500
– – ﹤0.01% 3200
2022
Q1 		$2K Hold
500
– – ﹤0.01% 3136
2021
Q4 		$2K Hold
500
– – ﹤0.01% 3048
2021
Q3 		$2K Buy
500
+499
+49,900% +$1.97K ﹤0.01% 3030
2021
Q2 		$0 Buy
+1
New +$4 ﹤0.01% 7476
2018
Q4 		– Sell
-250
Closed -$3K – 2287
2018
Q3 		$3K Hold
250
– – ﹤0.01% 2309
2018
Q2 		$3K Buy
+250
New +$3.13K ﹤0.01% 2165

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steward Partners Investment Advisory's CBAY Position: Q1 2024 in Review

Steward Partners Investment Advisory sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 17,600 shares — an estimated $416K sold.

Steward Partners Investment Advisory first reported a position in CBAY in Q2 2018 and held it in 12 quarters. The position peaked at $416K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Steward Partners Investment Advisory reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 17,600 Cymabay Therapeutics shares in Q1 2024, an estimated $416K.
  • Steward Partners Investment Advisory first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 12 quarters.
  • Steward Partners Investment Advisory's Cymabay Therapeutics position peaked at $416K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.